Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients

Rajiv Dhand, Alexander Duarte, Amal Jubran, John W. Jenne, James B. Fink, Patrick J. Fahey, Martin J. Tobin

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

In nonintubated patients, metered-dose inhalers (MDIs) are accepted as the most convenient, efficient, and cost effective method of administering inhaled bronchodilators. Recent studies have demonstrated the efficacy of MDIs in ventilator-supported patients; however, the optimal dose of a bronchodilator from a MDI is unknown. We determined the response to increasing doses of albuterol administered by a MDI and cylindrical spacer to 12 mechanically ventilated patients with chronic obstructive pulmonary disease (COPD). Four, eight, and 16 puffs of albuterol were given at 15-min intervals. Rapid airway occlusions were performed before and at 5-min intervals after albuterol for 80 min. Respiratory mechanics were also measured for 60 min in another group of seven patients with COPD who received four puffs of albuterol. Significant decrease in airway resistance occurred after administration of albuterol (p < 0.001). The decrease in airway resistance with four puffs of albuterol was comparable to that observed with cumulative doses of 17 puffs (p = 0.12) and 28 puffs (p = 0.25). Heart rate increased significantly (p < 0.01) after a cumulative dose of 28 puffs. The decrease in airway resistance was sustained for 60 min in the group that received only four puffs of albuterol (p < 0.003). In conclusion, four puffs of albuterol given by a MDI and spacer provided the best combination of bronchodilator effect and safety in stable mechanically ventilated patients with COPD.

Original languageEnglish (US)
Pages (from-to)388-393
Number of pages6
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume154
Issue number2
StatePublished - 1996
Externally publishedYes

Fingerprint

Metered Dose Inhalers
Albuterol
Bronchodilator Agents
Mechanical Ventilators
Airway Resistance
Chronic Obstructive Pulmonary Disease
Respiratory Mechanics
Heart Rate
Safety
Costs and Cost Analysis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients. / Dhand, Rajiv; Duarte, Alexander; Jubran, Amal; Jenne, John W.; Fink, James B.; Fahey, Patrick J.; Tobin, Martin J.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 154, No. 2, 1996, p. 388-393.

Research output: Contribution to journalArticle

Dhand, Rajiv ; Duarte, Alexander ; Jubran, Amal ; Jenne, John W. ; Fink, James B. ; Fahey, Patrick J. ; Tobin, Martin J. / Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients. In: American Journal of Respiratory and Critical Care Medicine. 1996 ; Vol. 154, No. 2. pp. 388-393.
@article{b09077670c7346d792cbe5db75105dd6,
title = "Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients",
abstract = "In nonintubated patients, metered-dose inhalers (MDIs) are accepted as the most convenient, efficient, and cost effective method of administering inhaled bronchodilators. Recent studies have demonstrated the efficacy of MDIs in ventilator-supported patients; however, the optimal dose of a bronchodilator from a MDI is unknown. We determined the response to increasing doses of albuterol administered by a MDI and cylindrical spacer to 12 mechanically ventilated patients with chronic obstructive pulmonary disease (COPD). Four, eight, and 16 puffs of albuterol were given at 15-min intervals. Rapid airway occlusions were performed before and at 5-min intervals after albuterol for 80 min. Respiratory mechanics were also measured for 60 min in another group of seven patients with COPD who received four puffs of albuterol. Significant decrease in airway resistance occurred after administration of albuterol (p < 0.001). The decrease in airway resistance with four puffs of albuterol was comparable to that observed with cumulative doses of 17 puffs (p = 0.12) and 28 puffs (p = 0.25). Heart rate increased significantly (p < 0.01) after a cumulative dose of 28 puffs. The decrease in airway resistance was sustained for 60 min in the group that received only four puffs of albuterol (p < 0.003). In conclusion, four puffs of albuterol given by a MDI and spacer provided the best combination of bronchodilator effect and safety in stable mechanically ventilated patients with COPD.",
author = "Rajiv Dhand and Alexander Duarte and Amal Jubran and Jenne, {John W.} and Fink, {James B.} and Fahey, {Patrick J.} and Tobin, {Martin J.}",
year = "1996",
language = "English (US)",
volume = "154",
pages = "388--393",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients

AU - Dhand, Rajiv

AU - Duarte, Alexander

AU - Jubran, Amal

AU - Jenne, John W.

AU - Fink, James B.

AU - Fahey, Patrick J.

AU - Tobin, Martin J.

PY - 1996

Y1 - 1996

N2 - In nonintubated patients, metered-dose inhalers (MDIs) are accepted as the most convenient, efficient, and cost effective method of administering inhaled bronchodilators. Recent studies have demonstrated the efficacy of MDIs in ventilator-supported patients; however, the optimal dose of a bronchodilator from a MDI is unknown. We determined the response to increasing doses of albuterol administered by a MDI and cylindrical spacer to 12 mechanically ventilated patients with chronic obstructive pulmonary disease (COPD). Four, eight, and 16 puffs of albuterol were given at 15-min intervals. Rapid airway occlusions were performed before and at 5-min intervals after albuterol for 80 min. Respiratory mechanics were also measured for 60 min in another group of seven patients with COPD who received four puffs of albuterol. Significant decrease in airway resistance occurred after administration of albuterol (p < 0.001). The decrease in airway resistance with four puffs of albuterol was comparable to that observed with cumulative doses of 17 puffs (p = 0.12) and 28 puffs (p = 0.25). Heart rate increased significantly (p < 0.01) after a cumulative dose of 28 puffs. The decrease in airway resistance was sustained for 60 min in the group that received only four puffs of albuterol (p < 0.003). In conclusion, four puffs of albuterol given by a MDI and spacer provided the best combination of bronchodilator effect and safety in stable mechanically ventilated patients with COPD.

AB - In nonintubated patients, metered-dose inhalers (MDIs) are accepted as the most convenient, efficient, and cost effective method of administering inhaled bronchodilators. Recent studies have demonstrated the efficacy of MDIs in ventilator-supported patients; however, the optimal dose of a bronchodilator from a MDI is unknown. We determined the response to increasing doses of albuterol administered by a MDI and cylindrical spacer to 12 mechanically ventilated patients with chronic obstructive pulmonary disease (COPD). Four, eight, and 16 puffs of albuterol were given at 15-min intervals. Rapid airway occlusions were performed before and at 5-min intervals after albuterol for 80 min. Respiratory mechanics were also measured for 60 min in another group of seven patients with COPD who received four puffs of albuterol. Significant decrease in airway resistance occurred after administration of albuterol (p < 0.001). The decrease in airway resistance with four puffs of albuterol was comparable to that observed with cumulative doses of 17 puffs (p = 0.12) and 28 puffs (p = 0.25). Heart rate increased significantly (p < 0.01) after a cumulative dose of 28 puffs. The decrease in airway resistance was sustained for 60 min in the group that received only four puffs of albuterol (p < 0.003). In conclusion, four puffs of albuterol given by a MDI and spacer provided the best combination of bronchodilator effect and safety in stable mechanically ventilated patients with COPD.

UR - http://www.scopus.com/inward/record.url?scp=0029781461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029781461&partnerID=8YFLogxK

M3 - Article

VL - 154

SP - 388

EP - 393

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2

ER -